INFLAMMATORY BOWEL DISEASE, SERIES #58

K.J. Schmidt, J. Büning, H. Lehnert, K. Fellermann

Cyclophosphamide as effective and safe treatment option with rapid acting potential in refractory severe Crohn's disease. Promising data imply a strong need for additional experience of this very encouraging treatment.

NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #81

Leigh Ann Mike

Although the exact pathophysiology of PRIS remains to be determined, impaired tissue metabolism caused by propofol infusion appears to be an important mechanism leading to complete cardiovascular collapse. Risk factors for developing PRIS include sepsis, severe cerebral injury, and high propofol doses. Early recognition of the manifestations is the key to managing PRIS.

A SPECIAL ARTICLE

Donald O. Castell, Jason R. Roberts

Prior to being diagnosed with achalasia, patients are frequently treated empirically for gastroesophageal reflux. The diagnosis is made in patients with a history suggestive of achalasia and confirmed by a combination of esophageal manometry, upper endoscopy, and barium esophagography. There are currently three different treatment modalities available—botulinum toxin injection, pneumatic dilation, and Heller myotomy.

A CASE REPORT

Rana Khan, Bishnu Sapkota, Grigoriy Goldenberg, Mohamed Mansour, Vincent Notar-Francesco, Maurice A. Cerulli

We present this case to remind clinicians that hemobilia is a possible cause of UGIB, especially in patients who present with jaundice, and in patients with biliary stents it can be fatal.

Departments Section